Biopharmaceutical company Gilead Sciences has completed the acquisition of YM BioSciences. A Gilead subsidiary acquired all YM's outstanding common shares as per the terms of a plan of arrangement. Thus, YM has become a wholly-owned ...
Tags: Gilead Sciences, YM BioSciences, acquisition